| 6QAQ: reference: Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design., O'Reilly M, Cleasby A, Davies TG, Hall RJ, Ludlow RF, Murray CW, Tisi D, Jhoti H, Drug Discov Today. 2019 Mar 14. pii: S1359-6446(19)30001-7. doi:, 10.1016/j.drudis.2019.03.009. PMID: 30878562 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).